A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE)

被引:13
作者
Djurovic, S. [1 ,2 ,3 ]
Kahler, A. K. [1 ,2 ]
Kulle, B. [4 ,5 ]
Jonsson, E. G. [6 ]
Agartz, I. [2 ,6 ,7 ]
Le Hellard, S. [8 ,9 ]
Hall, H. [6 ]
Jakobsen, K. D. [10 ]
Hansen, T. [10 ]
Melle, I. [2 ,3 ]
Werge, T. [10 ]
Steen, V. M. [8 ,9 ]
Andreassen, O. A. [2 ,3 ]
机构
[1] Ullevaal Univ Hosp, Inst Med Genet, Dept Med Genet, Div Psychiat, N-0407 Oslo, Norway
[2] Univ Oslo, Inst Psychiat, Oslo, Norway
[3] Ullevaal Univ Hosp, Dept Res & Dev, Div Psychiat, N-0407 Oslo, Norway
[4] Univ Oslo, Akershus Univ Hosp, Epi Gen Fac Div, Oslo, Norway
[5] Univ Oslo, Dept Biostat, Oslo, Norway
[6] Karolinska Hosp & Inst, HUBIN Project, Dept Clin Neurosci, Stockholm, Sweden
[7] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway
[8] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway
[9] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway
[10] Copenhagen Univ Hosp, Mental Hlth Ctr Sct Hans, Res Inst Biol Psychiat, Roskilde, Denmark
关键词
GRIK3; Glutamate; Candidate gene; Genetic association; Schizophrenia; SER310ALA POLYMORPHISM; RECEPTOR EXPRESSION; MESSENGER-RNAS; GLUR7; NEUROLEPTICS; LINKAGE; CORTEX; TRIAL; GENES; KA1;
D O I
10.1016/j.schres.2008.10.010
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is considerable evidence of altered glutamatergic signalling in schizophrenia and a polymorphic variant of the GRIK3 glutamate receptor gene on 1p34-33 has previously been associated to this psychotic disorder. We therefore conducted a systematic association study with 30 HapMap-selected tagging SNPs across GRIK3 in three independent samples of Scandinavian origin from the Scandinavian Collaboration of Psychiatric Etiology (SCOPE), including a total of 839 cases with schizophrenia spectrum and 1473 healthy controls. Four markers (rs6671364, rs17461259, rs472188, and rs535620) attained nominally significant P-values in both the genotypic (0.002, 0.02, 0.03, and 0.05, respectively) and allelic (0.001, 0.006, 0.03, and 0.02, respectively) association tests for the combined sample, and 2 additional markers (rs481047and rs1160751) displayed significance for the genotype (P-values: 0.03 and 0.04). Several haplotypes, that all included at least one of the four SNPs implicated by the single marker analysis, remained significant after adjustment for multiple testing using permutations with 10,000 shuffles. In addition we observed an association for two of the four significant GRIK3 markers (rs472188 and rs535620) to scores for negative symptoms on the PANSS scale. The present results, although not robust, support the importance of more extensive investigations of GRIK3, given its potential role in mediating risk for schizophrenia. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:242 / 248
页数:7
相关论文
共 25 条
[1]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[2]   Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and schizophrenia [J].
Begni, S ;
Popoli, M ;
Moraschi, S ;
Bignotti, S ;
Tura, GB ;
Gennarelli, M .
MOLECULAR PSYCHIATRY, 2002, 7 (04) :416-418
[3]  
Benes FM, 2001, HIPPOCAMPUS, V11, P482, DOI 10.1002/hipo.1065
[4]   Glutamate and schizophrenia: beyond the dopamine hypothesis. [J].
Joseph T. Coyle .
Cellular and Molecular Neurobiology, 2006, 26 (4) :365-384
[5]   Efficiency and power in genetic association studies [J].
de Bakker, PIW ;
Yelensky, R ;
Pe'er, I ;
Gabriel, SB ;
Daly, MJ ;
Altshuler, D .
NATURE GENETICS, 2005, 37 (11) :1217-1223
[6]   Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica [J].
DeLisi, LE ;
Mesen, A ;
Rodriguez, C ;
Bertheau, A ;
LaPrade, B ;
Llach, M ;
Riondet, S ;
Razi, K ;
Relja, M ;
Byerley, W ;
Sherrington, R .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (05) :497-508
[7]   Pedigree disequilibrium tests for multilocus haplotypes [J].
Dudbridge, F .
GENETIC EPIDEMIOLOGY, 2003, 25 (02) :115-121
[8]   A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia [J].
Goff, DC ;
Tsai, G ;
Levitt, J ;
Amico, E ;
Manoach, D ;
Schoenfeld, DA ;
Hayden, DL ;
McCarley, R ;
Coyle, JT .
ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (01) :21-27
[9]   Brain Expressed microRNAs Implicated in Schizophrenia Etiology [J].
Hansen, Thomas ;
Olsen, Line ;
Lindow, Morten ;
Jakobsen, Klaus D. ;
Ullum, Henrik ;
Jonsson, Erik ;
Andreassen, Ole A. ;
Djurovic, Srdjan ;
Melle, Ingrid ;
Agartz, Ingrid ;
Hall, Hakan ;
Timm, Sally ;
Wang, August G. ;
Werge, Thomas .
PLOS ONE, 2007, 2 (09)
[10]   Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence [J].
Harrison, PJ ;
Weinberger, DR .
MOLECULAR PSYCHIATRY, 2005, 10 (01) :40-68